Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Urologic Neoplasms. Found 7 abstracts

Balar AV, Castellano D, O'Donnell PH, Grivas P, Vuky J, Powles T, Plimack ER, Hahn NM, de Wit R, Pang L, Savage MJ, Perini RF, Keefe SM, Bajorin D, Bellmunt J. First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study. Lancet Oncol. 2017 Nov;18(11):1483-92.
Zibelman M, Plimack ER. Checkpoint Inhibitors and Urothelial Carcinoma: The Translational Paradigm. Oncology (Williston Park). 2016 Feb;30(2):160-2, 176.
Pond GR, Bellmunt J, Rosenberg JE, Bajorin DF, Regazzi AM, Choueiri TK, Qu AQ, Niegisch G, Albers P, Necchi A, Di Lorenzo G, Fougeray R, Wong YN, Sridhar SS, Ko YJ, Milowsky MI, Galsky MD, Sonpavde G. Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial design. Clin Genitourin Cancer. 2015 Feb;13(1):71-9.
Sonpavde G, Pond GR, Rosenberg JE, Bajorin DF, Regazzi AM, Choueiri TK, Qu AQ, Niegisch G, Albers P, Necchi A, Di Lorenzo G, Fougeray R, Dreicer R, Chen YH, Wong YN, Sridhar SS, Ko YJ, Milowsky MI, Galsky MD, Bellmunt J. Complete response as an intermediate end point in patients receiving salvage systemic therapy for urothelial carcinoma. Clin Genitourin Cancer. 2015 Apr;13(2):185-92.
Raman JD, Lin YK, Kaag M, Atkinson T, Crispen P, Wille M, Smith N, Hockenberry M, Guzzo T, Peyronnet B, Bensalah K, Simhan J, Kutikov A, Cha E, Herman M, Scherr D, Shariat SF, Boorjian SA. High rates of advanced disease, complications, and decline of renal function after radical nephroureterectomy. Urol Oncol. 2014 Jan;32(1):47e9-14.
Litwin S, Wong YN, Hudes G. Early stopping designs based on progression-free survival at an early time point in the initial cohort. Statistics in medicine. 2007 Oct 30;26(24):4400-15.
Aben KK, Baglietto L, Baffoe-Bonnie A, Coebergh JW, Bailey-Wilson JE, Trink B, Verbeek AL, Schoenberg MP, Alfred Witjes J, Kiemeney LA. Segregation analysis of urothelial cell carcinoma. Eur J Cancer. 2006 Jul;42(10):1428-33.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Urologic Neoplasms

Urologic Neoplasms Middle Aged drug therapy therapeutic use methods Treatment Outcome pathology mortality Aged Survival Analysis Phase II Clinical Trials as Topic Male Disease-Free Survival Female Prospective Studies Antineoplastic Agents Salvage Therapy Proportional Hazards Models statistics & numerical data adverse effects Urothelial carcinoma 80 and over Aged Transitional Cell Carcinoma Prognosis drug effects Urothelium metabolism Kidney Function Tests Follow-Up Studies Nephrectomy Time Factors Drug Administration Schedule enzymology genetics Drug Dose-Response Relationship Maximum Tolerated Dose Progression-free survival Renal-function changes Overall survival epidemiology Age Factors Clavien complications Risk Factors Immunotherapy Molecular Targeted Therapy Regression Analysis Advanced Monoclonal Antibodies-Humanized Ureter Biological Products Single-Blind Method physiopathology Drug Therapy Pedigree Partial response Cell Cycle Proteins Retrospective Studies Cohort Studies Perioperative Care Locally advanced disease Diffusion of Innovation Salvage systemic therapy Internationality Kaplan-Meier Estimate Number of prior regimens Intravenous Infusions Perioperative chemotherapy surgery immunology Neoplasm Invasiveness standards Cisplatin Netherlands Lymphatic Metastasis Glomerular Filtration Rate Complete response Non-US Gov't Research Support Cell Cycle Checkpoints Signal Transduction trends NIH Research Support-Extramural Neoplasm Staging Statistical Models Salvage therapy Carcinoma antagonists & inhibitors Clinical Trials as Topic Prior perioperative chemotherapy Cell Proliferation Outcome Assessment (Health Care) Patient Safety Postoperative Complications Advanced urothelial carcinoma Translational Medical Research
Last updated on Wednesday, February 05, 2020